2 hours What is Leerink Partnrs’ Estimate for VYGR Q3 Earnings?MarketBeat
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) – Equities research analysts at Leerink Partnrs issued their Q3 2024 EPS estimates for shares of Voyager Therapeutics in a research report issued on Wednesday, October 16th. Leerink Partnrs anal…
Earnings · Nasdaq 100 · Science
X